- Initial Statement of Beneficial Ownership (3)
November 04 2011 - 12:18PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Expires:
November 30, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
BROOKSIDE CAPITAL MANAGEMENT LLC
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/27/2011
|
3. Issuer Name
and
Ticker or Trading Symbol
IDENIX PHARMACEUTICALS INC [IDIX]
|
(Last)
(First)
(Middle)
JOHN HANCOCK TOWER, 200 CLARENDON STREET
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
BOSTON, MA 02116
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
10987500
|
I
|
See Footnote
(1)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
Brookside Capital Management, LLC ("BCM") is the sole general partner of Brookside Capital Investors II, L.P. ("BCI II") and BCI II is the sole general partner of Brookside Capital Trading Fund, L.P ("BCTF"). BCM and BCI II each may be deemed to share voting dispositive powers with respect to the shares held by BCTF. Each of BCM and BCI II disclaims beneficial ownership of such securtities, except to the extent of its pecunairy interest therein.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
BROOKSIDE CAPITAL MANAGEMENT LLC
JOHN HANCOCK TOWER, 200 CLARENDON STREET
BOSTON, MA 02116
|
|
X
|
|
|
Brookside Capital Trading Fund, L.P.
JOHN HANCOCK TOWER, 200 CLARENDON STREET
BOSTON, MA 02116
|
|
X
|
|
|
Brookside Capital Investors II, L.P.
JOHN HANCOCK TOWER, 200 CLARENDON STREET
BOSTON, MA 02116
|
|
X
|
|
|
Signatures
|
/S/ William Edward Pappendick, IV
|
|
11/3/2011
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024